Radioembolisation in Europe: A Survey Amongst CIRSE Members

Publication date

2018

Authors

Reinders, Margot T MORCID 0000-0002-0501-9427
Mees, Etienne
Powerski, Maciej J
Bruijnen, R C G
van den Bosch, MauriceISNI 0000000387826245
Lam, MarnixORCID 0000-0002-4902-9790
Smits, MaartenORCID 0000-0003-4735-655XISNI 0000000419580500

Editors

Advisors

Supervisors

Document Type

Article

Collections

Open Access logo

License

Abstract

INTRODUCTION: Radioembolisation of liver tumours demands many choices from the physician regarding planning of treatment and subsequent follow-up. METHODS: An online questionnaire was distributed amongst all members of the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) to investigate the current state of radioembolisation practice. RESULTS: The survey was completed by 60 centres. The increasing number of radioembolisation procedures may reflect that radioembolisation is increasingly recognised as a valuable treatment option in European cancer guidelines. Imaging modalities play an important role in decision making. Furthermore, there seems to be a trend towards less coil-embolisation of non-target vessels. In addition, type of microsphere, model for dose calculation, complications and future developments are evaluated in this article. CONCLUSIONS: This survey provides insight into the current state of radioembolisation practice across Europe.

Keywords

Interventionaloncology, Liver, Radioembolisation, Yttrium

Citation

Reinders, M T M, Mees, E, Powerski, M J, Bruijnen, R C G, van den Bosch, M A A J, Lam, M G E H & Smits, M L J 2018, 'Radioembolisation in Europe : A Survey Amongst CIRSE Members', Cardiovascular and Interventional Radiology, vol. 41, no. 10, pp. 1759-1789. https://doi.org/10.1007/s00270-018-1982-4